Drug intelligence / Profile preview

Renqing Changjue

Development stage
Unknown
Lead developer
Xizang Ganlu Tibetan Medicine
Administration
Oral
01

Overview

Renqing Changjue is a prominent traditional Tibetan medicine (TTM) classified as a "precious pill" (Rinchen Tselwa). It is a complex, multi-ingredient formulation comprising over 140 components, including processed minerals, metals (such as gold, silver, and copper), and numerous medicinal herbs like saffron and sandalwood. A key component is "Tsothel," a specially processed mercury sulfide preparation. Traditionally, it is used for a wide spectrum of ailments including gastrointestinal disorders, chronic inflammation, poisoning, and as a general health tonic. Modern clinical research, including studies registered in the Chinese Clinical Trial Registry, has begun to investigate its potential in treating metabolic disorders such as type 2 diabetes mellitus, specifically focusing on its immunomodulatory effects and ability to regulate inflammatory cytokines.

Brand names
Renqing Changjue
Other names
Rinchen Changjor仁青常觉Great Precious JewelRenqingchangjue
02

Targets

IL10 (Interleukin-10)

Beyond the preview

Go deeper on Renqing Changjue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renqing Changjue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call